Who said anything about a chart stock? And no matter the stock, news always trumps chart analysis. I was commenting that ATM offering sold in drips, especially into news pops, would be a better way to go. The current offering (needed to get us closer to human trials) not closing after almost 9 months and discounted from $0.05 to $0.027, and still not closing is news and it's bad news hanging over all the good news with the effective animal cancer treatments. Per the last quarterly, I'm very happy enough of the offering sold to remove bankruptcy as an immediate concern. But we don't have forever to get to human trials, and it will take more offerings than this one to get us there. In the long run we're all dead, maybe not as soon as cancer patients who are delayed having Radiogel as a treatment option due to slow progress, but dead just the same. Clock is ticking.
News 
Market Data 
Discover 
